These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 9931911)
1. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases]. Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911 [TBL] [Abstract][Full Text] [Related]
2. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089 [TBL] [Abstract][Full Text] [Related]
3. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer]. Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531 [TBL] [Abstract][Full Text] [Related]
4. [Multicenter phase II study of the Liver Metastases Study Group of weekly intra-arterial 24-hour high dose therapy with 5-FU and folinic acid (FA) in liver metastases of colorectal tumors]. Staib-Sebler E; Müller HH; Mattes P; Junginger T; Saeger HD; Lorenz M Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1441-4. PubMed ID: 9931906 [TBL] [Abstract][Full Text] [Related]
5. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165 [TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy. Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962 [TBL] [Abstract][Full Text] [Related]
7. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study. Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Barber FD; Mavligit G; Kurzrock R Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775 [TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer. Seki H; Ozaki T; Shiina M Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157 [TBL] [Abstract][Full Text] [Related]
11. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708 [TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer. Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990 [TBL] [Abstract][Full Text] [Related]
13. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259 [TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145 [TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413 [TBL] [Abstract][Full Text] [Related]
16. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion. Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673 [TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M; J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of 5-FU hepatic arterial infusion with l-leucovorin for patients with unresectable colorectal liver metastasis]. Mizushima T; Mizuno H; Sugiura T; Ito T; Udatsu Y; Okazawa M; Sugimura K; Tomokuni A; Kusumoto H; Nakagawa T; Kishimoto T; Iwase K; Izukura M Gan To Kagaku Ryoho; 2008 Jul; 35(7):1139-42. PubMed ID: 18633252 [TBL] [Abstract][Full Text] [Related]
19. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990 [TBL] [Abstract][Full Text] [Related]
20. [HAI chemotherapy for liver metastases of colorectal cancer]. Matsuoka H; Maeda K; Hanai T; Sato H; Masumori K; Koide Y; Katsuno H; Agata T; Noro T; Honda K; Shiota M; Ozeki S; Hatta K; Morise Z; Sugioka A; Ota H Gan To Kagaku Ryoho; 2010 Jul; 37(7):1303-6. PubMed ID: 20647714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]